Related Experiment Videos
Decrease of hepatic catalase level by treatment with diallyl sulfide and garlic homogenates in rats and mice
1Laboratory for Cancer Research, College of Pharmacy, Rutgers University, Piscataway, NJ 08854, USA.
Journal of Biochemical and Molecular Toxicology
|March 31, 1999
Summary
Diallyl sulfide (DAS) from garlic significantly reduces hepatic catalase activity in rats and mice. This effect was observed with both DAS and garlic homogenates, but not with its metabolite diallyl sulfone in vitro.
Area of Science:
- Biochemistry
- Toxicology
- Nutritional Science
Background:
- Diallyl sulfide (DAS) is a garlic-derived compound known for inhibiting chemical carcinogenicity in animal models.
- Garlic compounds, including DAS, are investigated for their potential health benefits and biological activities.
- Catalase, glutathione peroxidase, and superoxide dismutase are key antioxidant enzymes involved in cellular defense against oxidative stress.
Purpose of the Study:
- To investigate the impact of Diallyl sulfide (DAS) and garlic homogenates on the activity of hepatic and extrahepatic antioxidant enzymes.
- To determine the effect of DAS treatment duration and dosage on catalase activity.
- To assess the role of diallyl sulfone (DASO2), a metabolite of DAS, on catalase activity.
Main Methods:
- Male Sprague-Dawley rats and A/J mice were administered varying doses of DAS and garlic homogenates via intragastric gavage.
- Enzyme activities of catalase, glutathione peroxidase, and superoxide dismutase were measured in liver and other tissues (kidney, lung, brain, heart, erythrocytes).
- Western blot analysis was used to evaluate liver catalase protein levels following DAS treatment.
- In vitro assays were performed to test the direct inhibitory effects of DAS and DASO2 on catalase activity.
Main Results:
- DAS treatment (50 or 200 mg/kg daily for 8 days) dose-dependently decreased hepatic catalase activity by 55% and 95%, respectively.
- Extended DAS treatment (29 days) and short-term high-dose treatment (200 mg/kg for 1-7 days) also significantly reduced liver catalase activity.
- Western blot confirmed that DAS treatment led to decreased liver catalase protein levels.
- Garlic homogenates (2 or 4 g/kg daily for 7 days) reduced liver catalase activity by 35% in rats.
- Neither DAS nor its metabolite DASO2 inhibited catalase activity in vitro.
- No significant changes in superoxide dismutase and glutathione peroxidase activities were observed in the treated tissues.
Conclusions:
- Diallyl sulfide and garlic homogenates effectively decrease hepatic catalase levels in rats and mice.
- The reduction in catalase activity appears to be mediated by decreased protein expression rather than direct enzyme inhibition.
- The observed effects are specific to hepatic catalase, with minimal impact on other antioxidant enzymes or catalase in other tissues.